{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:36:13Z","timestamp":1771076173813,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["SR\/S0\/HS-0043\/2012"],"award-info":[{"award-number":["SR\/S0\/HS-0043\/2012"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11010-021-04206-1","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:03:07Z","timestamp":1624518187000},"page":"3923-3933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of interleukin-18 genotypes (\u2212607C\u2009>\u2009A) and (\u2212137 G\u2009>\u2009C) with the hepatitis B virus disease progression to hepatocellular carcinoma"],"prefix":"10.1007","volume":"476","author":[{"given":"Taqveema","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roli","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Rani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renuka","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Ola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuti","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh Kumar","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0284-4517","authenticated-orcid":false,"given":"Jyotdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"4206_CR1","first-page":"249","volume":"6","author":"AF Afifi","year":"2016","unstructured":"Afifi AF, Basha OM, Saleem WM (2016) Evaluation of serum nitric oxidase as a diagnostic and prognostic marker in patients with hepatocellular carcinoma. Indian J Appl Res 6:249\u2013255","journal-title":"Indian J Appl Res"},{"key":"4206_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000050029","volume":"44","author":"X Ding","year":"2001","unstructured":"Ding X, Mizokami M, YaI G et al (2001) Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shangai, China. Intervirolgy 44:43\u201347","journal-title":"Intervirolgy"},{"key":"4206_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","volume":"60","author":"R Garzon","year":"2009","unstructured":"Garzon R, Calin GA, Croce CM (2009) Micro-RNAs in cancer. Annu Rev Med 60:167\u2013179","journal-title":"Annu Rev Med"},{"key":"4206_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-2007-1007107","volume":"19","author":"MJ Koziel","year":"1999","unstructured":"Koziel MJ (1999) Cytokines in viral hepatitis. Semin Liver Dis 19:157\u2013169","journal-title":"Semin Liver Dis"},{"key":"4206_CR5","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.4049\/jimmunol.167.12.6701","volume":"167","author":"K Kakimi","year":"2001","unstructured":"Kakimi K, Lane TE, Fv C, Guidotti LG (2001) Cutting edge: inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol 167:6701\u20136705","journal-title":"J Immunol"},{"key":"4206_CR6","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1158\/0008-5472.CAN-15-1548","volume":"76","author":"GJ Markowitz","year":"2016","unstructured":"Markowitz GJ, Yang P, Fu J et al (2016) Inflammation-dependent IL18 signaling restricts hepatocellular carcinoma growth by enhancing the accumulation and activity of tumor-infiltrating lymphocytes. Cancer Res 76:2394\u20132405","journal-title":"Cancer Res"},{"key":"4206_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4049\/jimmunol.164.1.64","volume":"164","author":"T Fukao","year":"2000","unstructured":"Fukao T, Matsuda S, Koyasu S (2000) Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-\u03b3 production by dendritic Cells. J Immunol 164:64\u201371","journal-title":"J Immunol"},{"key":"4206_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1399-0039.2007.00865.x","volume":"70","author":"H Nattiya","year":"2007","unstructured":"Nattiya H, Manonom C, Tangkijvanich P, Poovorawan Y (2007) Association of interleukin-18 gene polymorphism [-607A\/A genotype] with susceptibility to chronic hepatitis B virus infection. Tissue Antigens 70:160\u2013173","journal-title":"Tissue Antigens"},{"key":"4206_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s13277-013-1151-y","volume":"35","author":"P Xia","year":"2014","unstructured":"Xia P, Zhou M, Dong DS et al (2014) Association of polymorphisms in interleukin-18 and interleukin-28B genes with outcomes of hepatitis B virus infections: a meta-analysis. Tumour Biol 35:1129","journal-title":"Tumour Biol"},{"key":"4206_CR10","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/jmv.24225","volume":"87","author":"SC Ferreira","year":"2015","unstructured":"Ferreira SC, Chach\u00e1 SF, Souza FF, Teixeira AC, Santana RC (2015) IL-18, TNF, and IFN-\u03b3 alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury. J Med Virol 87:1689\u20131696","journal-title":"J Med Virol"},{"issue":"3","key":"4206_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4254\/wjh.v4.i3.105","volume":"4","author":"N Li","year":"2012","unstructured":"Li N, Gao YF, Zhang TC et al (2012) Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol 4(3):105\u2013109","journal-title":"World J Hepatol"},{"key":"4206_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/309721","author":"OP Khripko","year":"2008","unstructured":"Khripko OP, Sennikova NS, Lopatnikova JA et al (2008) Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononuclear cells from healthy donors. Mediat Inflamm. https:\/\/doi.org\/10.1155\/2008\/309721","journal-title":"Mediat Inflamm"},{"issue":"1","key":"4206_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43066-020-00062-8","volume":"10","author":"AA Eldesoky","year":"2020","unstructured":"Eldesoky AA, Fateh Ahmed NA, Zaghloul HE et al (2020) Interleukin-18 polymorphism as a diagnostic tumor marker for hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Egypt Liver J 10(1):1\u20136","journal-title":"Egypt Liver J"},{"issue":"6","key":"4206_CR14","first-page":"a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-\u03baB in inflammation. CSH Perspect Biol 1(6):a001651","journal-title":"CSH Perspect Biol"},{"key":"4206_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1006\/cyto.2001.0914","volume":"14","author":"D Novick","year":"2001","unstructured":"Novick D, Schwartsburd B, Pinkus R et al (2001) A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18. Cytokine 14:334\u2013342","journal-title":"Cytokine"},{"key":"4206_CR16","first-page":"15","volume":"11","author":"S Lebel-Binay","year":"2000","unstructured":"Lebel-Binay S, Berger A, Zinzindohou\u00e9 F et al (2000) Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw 11:15\u201326","journal-title":"Eur Cytokine Netw"},{"key":"4206_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jceh.2014.12.004","volume":"4","author":"P Puri","year":"2014","unstructured":"Puri P (2014) Tackling the hepatitis B disease burden in India. J Clin Exp Hepatol 4:312\u2013319","journal-title":"J Clin Exp Hepatol"},{"key":"4206_CR18","first-page":"2971","volume":"49","author":"FB Hollinger","year":"2001","unstructured":"Hollinger FB, Liang TJ, Knipe DM et al (2001) Hepatitis B: the virus and disease. Hepatology 49:2971\u20133036","journal-title":"Hepatology"},{"key":"4206_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12016-008-8091-0","volume":"36","author":"F Tacke","year":"2009","unstructured":"Tacke F, Luedde T, Trautwein C (2009) Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 36:4\u201312","journal-title":"Clin Rev Allergy Immunol"},{"key":"4206_CR20","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3748\/wjg.v24.i11.1228","volume":"1","author":"AN Zekri","year":"2018","unstructured":"Zekri AN, El Deeb S, Bahnassy AA et al (2018) Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions. World J Gatroenterol 1:1228\u20131238","journal-title":"World J Gatroenterol"},{"key":"4206_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/cncr.20842","volume":"103","author":"A Nieters","year":"2005","unstructured":"Nieters A, Yuan JM, Sun CL et al (2005) Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer 103:740\u2013748","journal-title":"Cancer"},{"key":"4206_CR22","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.3748\/wjg.v22.i30.6800","volume":"22","author":"MF Dondeti","year":"2016","unstructured":"Dondeti MF, El-Maadawy EA, Talaat RM (2016) Hepatitis-related hepatocellular carcinoma: insights into cytokine gene polymorphisms. World J Gastroenterol 22:6800\u20136816","journal-title":"World J Gastroenterol"},{"key":"4206_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.gene.6363645","volume":"1","author":"J Bidwell","year":"1999","unstructured":"Bidwell J, Keen L, Gallagher G et al (1999) Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1:3\u201319","journal-title":"Genes Immun"},{"key":"4206_CR24","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.4254\/wjh.v7.i11.1572","volume":"7","author":"R Saxena","year":"2015","unstructured":"Saxena R, Kaur J (2015) Th1\/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma. World J Hepatol 7:1572\u20131580","journal-title":"World J Hepatol"},{"key":"4206_CR25","first-page":"737","volume":"139","author":"R Saxena","year":"2014","unstructured":"Saxena R, Chawla Y, Kaur J (2014) Association of Interleukin-10 with HBV mediated disease progression in Indian population. Indian J Med Res 139:737\u2013745","journal-title":"Indian J Med Res"},{"key":"4206_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ajhb.22562","volume":"26","author":"R Saxena","year":"2014","unstructured":"Saxena R, Chawla Y, Kaur J (2014) IL-6[-572\/-597] polymorphism and expression in HBV disease chronicity in Indian population. Am J Hum Biol 26:549\u2013555","journal-title":"Am J Hum Biol"},{"key":"4206_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1089\/jir.2012.0093","volume":"33","author":"R Saxena","year":"2013","unstructured":"Saxena R, Chawla Y, Kaur J (2013) IL-1 polymorphism and expression in HBV mediated disease outcome in India. J Interf Cytokine Res 33:80\u201389","journal-title":"J Interf Cytokine Res"},{"key":"4206_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0065-2776(08)60389-2","volume":"70","author":"H Okamura","year":"1998","unstructured":"Okamura H, Tsutsui H, Kashiwamura S et al (1998) Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70:281\u2013312","journal-title":"Adv Immunol"},{"key":"4206_CR29","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/eji.1830260736","volume":"26","author":"MJ Micallef","year":"1996","unstructured":"Micallef MJ, Ohtsuki T, Kohno K et al (1996) Interferon-\u03b3-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12. Eur J Immunol 26:1647\u20131651","journal-title":"Eur J Immunol"},{"key":"4206_CR30","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1073\/pnas.94.8.3948","volume":"94","author":"T Yoshimoto","year":"1997","unstructured":"Yoshimoto T, Okamura H, Tagawa YI et al (1997) Interleukin 18 together with interleukin12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA 94:3948\u20133953","journal-title":"Proc Natl Acad Sci USA"},{"key":"4206_CR31","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.4049\/jimmunol.157.9.3967","volume":"157","author":"H Tsutsui","year":"1996","unstructured":"Tsutsui H, Nakanishi K, Matsui K et al (1996) IFN-\u03b3-inducing factor up-regulates fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 157:3967\u20133973","journal-title":"J Immunol"},{"key":"4206_CR32","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.4049\/jimmunol.159.8.3961","volume":"159","author":"H Tsutsui","year":"1997","unstructured":"Tsutsui H, Matsui K, Kawada N et al (1997) IL-18 accounts for both TNF-\u03b1- and fasligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 159:3961\u20133967","journal-title":"J Immunol"},{"key":"4206_CR33","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/eji.1830260736","volume":"26","author":"MJ Micallef","year":"1996","unstructured":"Micallef MJ, Ohtsuki T, Kohno K et al (1996) Interferon-\u03b3-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-\u03b3 production. Eur J Immunol 26:1647\u20131651","journal-title":"Eur J Immunol"},{"key":"4206_CR34","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.4049\/jimmunol.159.5.2125","volume":"15","author":"HJ Ahn","year":"1997","unstructured":"Ahn HJ, Maruo S, Tomura M et al (1997) A mechanism underlying synergy between IL-12 and IFN-\u03b3-inducing factor in enhanced production of IFN-\u03b3. J Immunol 15:2125\u20132131","journal-title":"J Immunol"},{"key":"4206_CR35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/02841860902878145","volume":"48","author":"A Farjadfar","year":"2008","unstructured":"Farjadfar A, Mojtahedi Z, Ghaderi A et al (2008) Interleukin-18 promoter polymorphism isassociated with lung cancer: a case-control study. Acta Oncol 48:971\u2013976","journal-title":"Acta Oncol"},{"key":"4206_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4274\/tjh.2014.0126","volume":"32","author":"S Yalcin","year":"2015","unstructured":"Yalcin S, Mutlu P, Cetin T et al (2015) The -137G\/C polymorphism in interleukin-18 gene promoter contributes to chronic lymphocytic and chronic myelogenous leukemia riskin turkish patients. Turk J Haematol 32:311\u2013316","journal-title":"Turk J Haematol"},{"key":"4206_CR37","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.humimm.2013.04.029","volume":"74","author":"AC Teixeira","year":"2013","unstructured":"Teixeira AC, Martinelli AC, Donadi EA (2013) Role of alleles and genotypes of polymorphisms of IL-18 [-607 C\/A; and -137 C\/G], IFN-\u03b3 [+874 A\/T] and TNF-\u03b1 [-238 A\/G and -308 A\/G] and HLA-G genes in the susceptibility of hepatocellular carcinoma. Hum Immunol 74:1024\u20131029","journal-title":"Hum Immunol"},{"key":"4206_CR38","first-page":"352","volume":"24","author":"QX Zhang","year":"2016","unstructured":"Zhang QX, Yao YQ, Li SL et al (2016) Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus. Chin J Hepatol 24:352\u2013357","journal-title":"Chin J Hepatol"},{"key":"4206_CR39","first-page":"1420","volume":"3","author":"FT Hasan","year":"2017","unstructured":"Hasan FT, Hassan Nai HM (2017) Association of gene polymorphisms and serum levels of IL-18 with the susceptibility to infection with hepatitis B virus. J Infect Dis Med 3:1420","journal-title":"J Infect Dis Med"},{"key":"4206_CR40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3390\/ijms20071563","volume":"20","author":"WS Chang","year":"2019","unstructured":"Chang WS, Shen TC, Yeh WL et al (2019) Contribution of inflammatory cytokine Interleukin-18 genotypes to the renal cell carcinoma. Int J Mol Sci 20:1563","journal-title":"Int J Mol Sci"},{"key":"4206_CR41","first-page":"8433","volume":"28","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Wang S, Zhang Z et al (2017) Association of IL-18 genetic polymorphisms and haplotypes with breast cancer risk in a Chinese population. Biomed Res J 28:8433\u20138437","journal-title":"Biomed Res J"},{"key":"4206_CR42","doi-asserted-by":"publisher","first-page":"556","DOI":"10.7150\/ijms.15853","volume":"13","author":"HK Lau","year":"2016","unstructured":"Lau HK, Hsieh MI, Yang SF et al (2016) Association between interleukin-18 polymorphisms and hepatocellular carcinoma occurrence and clinical progression. Int J Med Sci 13:556\u2013561","journal-title":"Int J Med Sci"},{"key":"4206_CR43","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1440-1746.2009.05791.x","volume":"24","author":"MR Haghshenas","year":"2009","unstructured":"Haghshenas MR, Hosseini SV, Mahmoudi M et al (2009) IL-18 serum level and IL-18promoter gene polymorphism in Iranian patients with gastrointestinal cancers. J Gastroenterol Hepatol 24:1119\u20131122","journal-title":"J Gastroenterol Hepatol"},{"key":"4206_CR44","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/07853890310021580","volume":"36","author":"SL You","year":"2004","unstructured":"You SL, Yang HI, Chen CJ (2004) Seropositivity of hepatitis B e antigen and hepatocellular carcinoma. Ann Med 36:215\u2013224","journal-title":"Ann Med"},{"key":"4206_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJMoa013215","volume":"347","author":"HI Yang","year":"2002","unstructured":"Yang HI, Lu SN, Liaw YF et al (2002) Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347:168\u2013174","journal-title":"N Engl J Med"},{"key":"4206_CR46","doi-asserted-by":"publisher","first-page":"81350","DOI":"10.18632\/oncotarget.18531","volume":"46","author":"ZJ Dai","year":"2017","unstructured":"Dai ZJ, Liu XH, Wang M et al (2017) IL-18 polymorphisms contribute to hepatitis B virus-related cirrhosis and hepatocellular carcinoma susceptibility in Chinese population: a case-control study. Oncotarget 46:81350\u201381360","journal-title":"Oncotarget"},{"key":"4206_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-015-0223-z","author":"J Bao","year":"2015","unstructured":"Bao J, Lu Y, Deng Y, Rong C et al (2015) Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case\u2013control study. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-015-0223-z","journal-title":"Cancer Cell Int"},{"key":"4206_CR48","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/sj.jid.5700294","volume":"126","author":"K Dai","year":"2006","unstructured":"Dai K, Sayama YK, Tohyama M et al (2006) SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA induced innate immune response of human keratinocytes. J Investig Dermatol 126:1574\u20131581","journal-title":"J Investig Dermatol"},{"key":"4206_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1128\/MMBR.65.1.131-150.2001","volume":"65","author":"TH Mogensen","year":"2001","unstructured":"Mogensen TH, Paludan SR (2001) Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev 65:131\u2013150","journal-title":"Microbiol Mol Biol Rev"},{"key":"4206_CR50","doi-asserted-by":"publisher","first-page":"29445","DOI":"10.1074\/jbc.273.45.29445","volume":"273","author":"TL Born","year":"1998","unstructured":"Born TL, Thomassen E, Bird TA et al (1998) Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 273:29445\u201329450","journal-title":"J Biol Chem"},{"key":"4206_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/intimm\/dxh186","volume":"17","author":"K Takeda","year":"2005","unstructured":"Takeda K, Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17:1\u201314","journal-title":"Int Immunol"},{"key":"4206_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1348-0421.2004.tb03500.x","volume":"48","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Funami K, Seya T (2004) Toll like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol 48:147\u2013154","journal-title":"Microbiol Immunol"},{"key":"4206_CR53","first-page":"2094","volume":"9","author":"S Albani","year":"2010","unstructured":"Albani S, Cervia D, Sugama S et al (2010) Interleukin 18 in CNS. J Neuroinflamm 9:2094\u20132099","journal-title":"J Neuroinflamm"},{"key":"4206_CR54","doi-asserted-by":"publisher","first-page":"639103","DOI":"10.3389\/fmed.2021.639103","volume":"8","author":"Y Hirooka","year":"2021","unstructured":"Hirooka Y, Nozaki Y (2021) Interleukin-18 in inflammatory kidney disease. Front Med 8:639103. https:\/\/doi.org\/10.3389\/fmed.2021.639103","journal-title":"Front Med"},{"key":"4206_CR55","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.4049\/jimmunol.1002046","volume":"185","author":"MH Zaki","year":"2010","unstructured":"Zaki MH, Vogel P, Malapel MP et al (2010) IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 185:4912\u20134920","journal-title":"J Immunol"},{"key":"4206_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/bbrc.1998.8236","volume":"244","author":"H Kojima","year":"1998","unstructured":"Kojima H, Takeuchi M, Kurimoto M et al (1998) Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 Cells. Biochem Biophys Res Commun 244:183\u2013186","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04206-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04206-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04206-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T09:02:54Z","timestamp":1675501374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04206-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4206"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04206-1","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}